Authored By: Sarah
03 Nov 2021

Age-related Macular Degeneration Market | Discover Top Segments, Trends, Drivers and Challenges
Market Forecast and Growth Projections 2021-2025

The Global age-related macular degeneration market is expected to grow by $ 4.00 bn, accelerating at a CAGR of almost 5.93% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.


For a snapshot of our exhaustive research analysis and insights:  Request for Our Free Sample Report


Age-related Macular Degeneration Market: Segments and Leading  Regions

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • The report segments the market by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW). Each market segment is analyzed for past performance leading to future growth projections based on current market scenario.
  • The North America region emerged as the leading segment in recent years. 44% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Age-related Macular Degeneration Market size.

Age-related Macular Degeneration Market Size to Grow by $ 4.00 bn through 2021-2025 | Leading Segments and Market Trends

Age-related Macular Degeneration Market: Trends, Drivers, Challenges to impact growth

Our report helps market players to discover the various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will provide clients with all the information they would require for designing a growth strategy for their business.

  • A significant factor in driving the growth of the Age-related Macular Degeneration Market will be the high prevalence of amd.
  • Strong pipeline and expected approvals is another factor that will be instrumental in driving market growth during the forecast period.
  • One of the key challenges that market players need to contend with in order to achieve further success is the Lack of approved therapies for dry AMD.

Age-related Macular Degeneration Market: Vendor Analysis

  • The market is fragmented.
  • The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
  • AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc. are some of the major market participants.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 5.93%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 4.00 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    High prevalence of AMD will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    44% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW)

Age-related Macular Degeneration Market: Key Geographic that will Drive Growth

Regional Growth Analysis and Market Trends 2021-2025

The age-related macular degeneration market is set to grow by $ 4.00 bn, accelerating at a CAGR of almost 6% during the forecast period. This research report analyses the growth trajectory of the market with a purview to prevalent market scenario, trends, and drivers. It also provides competitive bench-marking of the key market players and their product portfolios.


For a glimpse into our research analysis and insights: Request for our Free Sample Report


Age-related Macular Degeneration Market: North America to lead market growth during the forecast period

  • 44% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Age-related Macular Degeneration Market size.
  • Rise in High prevalence of amd will be a significant factor in driving the growth of the age-related macular degeneration market. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will thus enable clients to assess their play in the market and plan for growth opportunities.
  • Market is segmented by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW).

Age-related Macular Degeneration Market Size to Grow by $ 4.00 bn through 2021-2025 | Leading Segments and Market Trends

Age-related Macular Degeneration Market: Key Competitors

The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

For more insights on this market: Download a Free Sample Report

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 6%.
     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 4.00 bn through 2021-2025.
     
  3. What is a key factor driving this market?
    High prevalence of AMD will drive market growth over the forecast period.
     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.
     
  5. Which is the leading geographic region for this market:
    44% growth will originate from North America
     
  6. Who are the leading market vendors?
    The leading vendors in this market are AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.
     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW).

Age-related Macular Degeneration Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

The age-related macular degeneration market and it is expected to grow by $ 4.00 bn, accelerating at a CAGR of almost 6% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers to enable growth projections and insights. This analytical examination of the market will enable businesses to plan and set the path for future growth prospects. 


Rely on our business insights to implement a COVID-19 Recovery Plan: Request for Free Sample Report


Age-related Macular Degeneration Market: Market Segments and Key Trends

This report provides a detailed analysis of the market by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW). 44% of the market growth will originate from North America during the forecast period. This research report provides a detailed analysis of all the segments, key trends, and challenges that are likely to influence growth.

Age-related Macular Degeneration Market: Top Drivers to Boost Demand

The High prevalence of AMD is one of the primary factors driving the growth of the age-related macular degeneration market. The report provides a detailed study of all the factors that are likely to boost the market. An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals. 

Age-related Macular Degeneration Market Size to Grow by $ 4.00 bn through 2021-2025 | Leading Segments and Market Trends

Vendor Analysis: AbbVie Inc., Alkeus Pharmaceuticals Inc. and Amgen Inc. are key growth contributors

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Age-related Macular Degeneration Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive age-related macular degeneration market growth during the next five years
  • Precise estimation of the age-related macular degeneration market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the age-related macular degeneration market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of age-related macular degeneration market vendors

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 6%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 4.00 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    High prevalence of AMD will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    44% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Wet AMD and Dry AMD) and Geography (North America, Europe, Asia, and ROW)
Read News Read Less
Interested in this report?
Get your sample now!
Technavio